BEKSAÇ, M. Et Al. 2009. Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.. 51st Annual Meeting of the American-Society-of-Hematology , (Louisiana, United States Of America), 746-747.

BEKSAÇ, M., Haznedar, R., Firatli-Tuglular, T., Ozdogu, H., Aydogdu, I., Konuk, N., ... Sucak, G.(2009). Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group. . 51st Annual Meeting of the American-Society-of-Hematology (pp.746-747). Louisiana, United States Of America

BEKSAÇ, MERAL Et Al. "Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.," 51st Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 2009

BEKSAÇ, MERAL Et Al. "Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.." 51st Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America, pp.746-747, 2009

BEKSAÇ, M. Et Al. (2009) . "Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.." 51st Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America, pp.746-747.

@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.}, congress name={51st Annual Meeting of the American-Society-of-Hematology}, city={Louisiana}, country={United States Of America}, year={2009}, pages={746-747} }